The Alliance for Safe Biologic Medicines (ASBM) executive director, Michael Reilly, was featured in a Globe & Mail video series on biosimilars. Mr. Reilly provides a global perspective on biosimilars, with a focus on why manufacturing matters. Globe & Mail is the national newspaper for Canada and this new online series will provide viewers with easy to watch videos to help inform Canadians on the future of biosimilars.
In the video, Mr. Reilly says:
“The Alliance for Safe Biologic Medicines is trying to bring a global perspective to the issues around biologic medicines, biosimilars, and patient safety. Biologics are the future of medicine and one of the greatest challenges we face is the need to educate.
“We’re going to make sure that we focus first on patient safety and we believe that by doing that we will end up giving a longer term viability for the program of biosimilars as a result.”
Watch the video.
Other video participants included Karen Burke from Amgen Canada who provided a general perspective on biosimilars and Jackie Manthorne, CEO from the Canadian Cancer Survivor Network, who provided the patient perspective.